6550--Blood Culture Detection, ID and Susceptibility Testing

SOL #: 36C24226Q0333Award Notice

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
242-NETWORK CONTRACT OFFICE 02 (36C242)
ALBANY, NY, 12208, United States

Place of Performance

Place of performance not available

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 6, 2026
2
Last Updated
May 5, 2026

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), Network Contracting Office 2, has awarded a sole-source, firm-fixed-price Blanket Purchase Agreement (BPA) to BIOMERIEUX INC. for Blood Culture Detection, Identification, and Antimicrobial Susceptibility Testing services and supplies. This award, identified under number 36C24226A0027, supports multiple VA Medical Centers (VAMCs) and is justified due to Biomerieux Inc. being the only responsible source capable of meeting unique requirements.

Scope of Work

The BPA covers critical laboratory services and supplies, including:

  • Bacterial identification system (Vitek MS Prime)
  • Susceptibility system (Vitek 2XL or Vitek 2)
  • Cost-Per-Kit (CPK) basis for Blood Culture, Identification, and Antimicrobial Susceptibility Testing
  • System capable of identifying yeast species
  • Blood culture incubation and growth detection system (Bact/Alert Virtuo) with compatible collection containers
  • Alert system for clinical laboratory areas
  • Common middleware solution (Maestra) These services ensure continuity of patient care at various VA facilities.

Contract Details

  • Awardee: BIOMERIEUX INC.
  • Award Number: 36C24226A0027
  • Award Date: May 4, 2026
  • Contract Type: Firm-Fixed Price (FFP) Blanket Purchase Agreement (BPA)
  • Duration: One base year with four one-year options
  • Estimated Value: Approvals up to $90,000,000 (for the BPA)
  • Set-Aside: Sole Source (restricted to "Only One Responsible Source" per FAR 12.201-1)
  • Locations: James J. Peters VA Medical Center (Bronx), East Orange VA Medical Center (NJ), Margaret Cochran Corbin VA Campus, Northport VA Medical Center, and Hudson Valley, Castle Point VA Medical Center.

Justification & Evaluation

This procurement was justified as a sole-source award to Biomerieux Inc. because market research conducted from January to March 2026 indicated no other small businesses (SDVOSB, VOSB) or other vendors could meet the unique technical requirements, specifically the identification of yeast species. Biomerieux Inc. was identified as the sole capable vendor and Original Equipment Manufacturer (OEM). This was not a competitive solicitation, and evaluation criteria for proposals were not applicable. Prices were determined to be fair and reasonable, with potential 3% increases in option years.

Additional Notes

  • Product Service Code (PSC): 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
  • NAICS Code: 334516 - Diagnostic Product Manufacturing (Small Business Standard: 1,000 employees)
  • Contact: Wilmen Joa, Contracting Officer, Wilmen.Joa@va.gov
  • The Buy American Act (BAA) applies and will be reviewed. The VA will continue to monitor the marketplace for future acquisitions.

People

Points of Contact

Wilmen JoaContracting OfficerPRIMARY

Files

Files

View
Download
Download
View
Download

Versions

Version 3Viewing
Award Notice
Posted: May 5, 2026
Version 2
Special Notice
Posted: May 5, 2026
View
Version 1
Special Notice
Posted: Feb 6, 2026
View
6550--Blood Culture Detection, ID and Susceptibility Testing | GovScope